Fate Therapeutics (NASDAQ:FATE) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:00 PM.
Here’s a brief overview of the earnings report.
Earnings
Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.
Revenue was down $491 thousand from the same period last year.
Overview of Past Earnings
In the previous quarter, the company …